Biotech | January 14, 2022
Evonik to build production plant for rhamnolipids in Slovakia
The new plant at Slovenská ?up?a site in Slovakia is scheduled to come on stream in two years
The new plant at Slovenská ?up?a site in Slovakia is scheduled to come on stream in two years
The agreement grants Brinter the distribution rights of GrowInk bioinks in many countries
The full transition of Viatris' biosimilars operations to Biocon Biologics in Europe represents another significant milestone
Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
The company expects to capture a 10 per cent share in Spain’s $6.34 million meropenem market and consolidate its position in other European countries
Smart-performance, fully biodegradable biopolymer sourced from renewable raw materials
Efgartigimod is approved in the United States as VYVGART for the treatment of adults with generalized myasthenia gravis
NDM disorders are a group of rare, inherited neuromuscular disorders which is characterized by the inability to relax muscles following voluntary contraction
Ryaltris is a fixed dose combination nasal spray that combines an antihistamine (Olopatadine) with a steroid (Mometasone Furoate) for treatment of allergic rhinitis
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)